SS&C Technologies Holdings

SSNC · NASDAQ

$86.92+$2.30 (+2.72%)TodayMarket closed · Oct 20, 5:40 PM ET

Prev close $84.62

SSNC analyst rating

BuyConsensus of 8 analysts over the last 12 months. 75% rate it a buy.

Strong buy1
Buy5
Hold2
Underperform0
Sell0

12-month price target · 11 analysts

Average $96.49 (+11.0% upside)

Low: $82.82
Now: $86.92
High: $117.60

Upgrades and downgrades

The latest rating actions, newest first

SSNC analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
RBC Capital	Aug 31, 2026	Maintains	Outperform	$92.00 → $101.00	64%
DA Davidson	Jul 27, 2026	Maintains	Buy	$96.00	57%
RBC Capital	Jul 24, 2026	Maintains	Outperform	$89.00 → $92.00	64%
Needham	Jul 24, 2026	Maintains	Buy	$90.00	45%
Jefferies	Jul 20, 2026	Maintains	Buy	$92.00 → $83.00	44%
JP Morgan	Jul 20, 2026	Maintains	Neutral	$94.00 → $87.00	63%
DA Davidson	Jul 15, 2026	Maintains	Buy	$96.00	57%
DA Davidson	Apr 27, 2026	Maintains	Buy	$96.00	57%
UBS	Apr 24, 2026	Maintains	Buy	$112.00 → $115.00	45%
Morgan Stanley	Apr 24, 2026	Maintains	Equal-Weight	$86.00 → $78.00	57%

The case for and against

Updated Oct 14, 2026

Bull case

SS&C Technologies Hldgs is attractive because it combines resilient, mission-critical financial software with recurring services, enabling broad-based demand across GlobeOp, GIDS, WITs, and Intralinks. In 2Q26, adjusted revenue reached $1.697B and adjusted EBITDA $671M with a 39.5% margin, while organic growth accelerated to 7.6% y/y and FY26 guidance was raised, reflecting strong license renewals, improved execution, and AI-driven efficiency gains. The company’s long record of roughly 80 acquisitions, $716M in first-half operating cash flow, and ongoing share repurchases supports EPS growth and margin expansion, while Blue Prism and other deals strengthen automation, scale, and cross-selling opportunities.

Bear case

SS&C Technologies Hldgs is facing weakening organic momentum, with Intelligent Automation & Analytics revenue down 1.0% and Healthcare down 3.1% y/y, while 3Q26 organic growth is expected to step down to 5.0% at the midpoint. Its outlook is constrained by heavy exposure to financial services activity, making revenue sensitive to AUM and trading volumes, and by client behavior shifts toward passive products that can defer spending and pressure pricing. The company’s long M&A-driven strategy, including about 80 acquisitions over 35 years and 2.8x net leverage at the end of 2025, adds integration and balance-sheet risk if growth slows or macro conditions worsen.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.